Below is a detailed analysis of the quarterly data for Alkyl Amines Chemicals Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
For Sales, as of Mar 2025, the value is 386.00 Cr.. The value appears strong and on an upward trend. It has increased from 371.00 Cr. (Dec 2024) to 386.00 Cr., marking an increase of 15.00 Cr..
For Expenses, as of Mar 2025, the value is 318.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 301.00 Cr. (Dec 2024) to 318.00 Cr., marking an increase of 17.00 Cr..
For Operating Profit, as of Mar 2025, the value is 68.00 Cr.. The value appears to be declining and may need further review. It has decreased from 71.00 Cr. (Dec 2024) to 68.00 Cr., marking a decrease of 3.00 Cr..
For OPM %, as of Mar 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 19.00% (Dec 2024) to 18.00%, marking a decrease of 1.00%.
For Other Income, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Dec 2024) to 9.00 Cr., marking an increase of 2.00 Cr..
For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 0.00 Cr..
For Depreciation, as of Mar 2025, the value is 18.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 18.00 Cr..
For Profit before tax, as of Mar 2025, the value is 59.00 Cr.. The value remains steady. There is no change compared to the previous period (Dec 2024) which recorded 59.00 Cr..
For Tax %, as of Mar 2025, the value is 22.00%. The value appears to be improving (decreasing) as expected. It has decreased from 26.00% (Dec 2024) to 22.00%, marking a decrease of 4.00%.
For Net Profit, as of Mar 2025, the value is 46.00 Cr.. The value appears strong and on an upward trend. It has increased from 44.00 Cr. (Dec 2024) to 46.00 Cr., marking an increase of 2.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 9.00. The value appears strong and on an upward trend. It has increased from 8.56 (Dec 2024) to 9.00, marking an increase of 0.44.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 7:20 am
Metric
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
446
476
484
501
616
846
993
1,242
1,542
1,683
1,441
1,572
Expenses
362
390
393
405
499
682
736
812
1,216
1,335
1,189
1,281
Operating Profit
85
87
91
95
118
164
257
430
326
348
252
291
OPM %
19%
18%
19%
19%
19%
19%
26%
35%
21%
21%
17%
19%
Other Income
2
2
2
1
2
4
40
6
14
9
14
30
Interest
12
10
8
8
8
15
10
6
3
3
4
1
Depreciation
10
11
13
14
16
23
27
29
35
45
59
71
Profit before tax
65
67
72
74
96
130
260
401
302
309
202
249
Tax %
34%
32%
31%
32%
33%
36%
17%
26%
26%
26%
26%
25%
Net Profit
43
45
50
50
64
84
215
295
225
229
149
186
EPS in Rs
8.41
8.91
9.77
9.87
12.61
16.42
42.21
57.91
44.04
44.75
29.12
36.39
Dividend Payout %
19%
18%
41%
20%
22%
20%
19%
17%
23%
22%
34%
27%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2014-2015
2015-2016
2016-2017
2017-2018
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
4.65%
11.11%
0.00%
28.00%
31.25%
155.95%
37.21%
-23.73%
1.78%
-34.93%
24.83%
Change in YoY Net Profit Growth (%)
0.00%
6.46%
-11.11%
28.00%
3.25%
124.70%
-118.74%
-60.94%
25.51%
-36.71%
59.77%
Alkyl Amines Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
13%
5 Years:
10%
3 Years:
1%
TTM:
9%
Compounded Profit Growth
10 Years:
15%
5 Years:
0%
3 Years:
-6%
TTM:
24%
Stock Price CAGR
10 Years:
35%
5 Years:
19%
3 Years:
-9%
1 Year:
-2%
Return on Equity
10 Years:
23%
5 Years:
21%
3 Years:
16%
Last Year:
14%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Alkyl Amines Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 20, the value is 5.00. This value is within the healthy range. There is no change compared to the previous period (Mar 19) which recorded 5.00.
For Basic EPS (Rs.), as of Mar 20, the value is 98.71. This value is within the healthy range. It has increased from 42.22 (Mar 19) to 98.71, marking an increase of 56.49.
For Diluted EPS (Rs.), as of Mar 20, the value is 98.44. This value is within the healthy range. It has increased from 42.10 (Mar 19) to 98.44, marking an increase of 56.34.
For Cash EPS (Rs.), as of Mar 20, the value is 109.66. This value is within the healthy range. It has increased from 51.66 (Mar 19) to 109.66, marking an increase of 58.00.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 20, the value is 262.88. It has increased from 185.71 (Mar 19) to 262.88, marking an increase of 77.17.
For Revenue From Operations / Share (Rs.), as of Mar 20, the value is 486.42. It has increased from 414.66 (Mar 19) to 486.42, marking an increase of 71.76.
For PBDIT / Share (Rs.), as of Mar 20, the value is 129.11. This value is within the healthy range. It has increased from 81.65 (Mar 19) to 129.11, marking an increase of 47.46.
For PBIT / Share (Rs.), as of Mar 20, the value is 115.93. This value is within the healthy range. It has increased from 70.22 (Mar 19) to 115.93, marking an increase of 45.71.
For PBT / Share (Rs.), as of Mar 20, the value is 118.25. This value is within the healthy range. It has increased from 62.98 (Mar 19) to 118.25, marking an increase of 55.27.
For Net Profit / Share (Rs.), as of Mar 20, the value is 96.48. This value is within the healthy range. It has increased from 40.22 (Mar 19) to 96.48, marking an increase of 56.26.
For NP After MI And SOA / Share (Rs.), as of Mar 20, the value is 98.63. This value is within the healthy range. It has increased from 42.18 (Mar 19) to 98.63, marking an increase of 56.45.
For PBDIT Margin (%), as of Mar 20, the value is 26.54. This value is within the healthy range. It has increased from 19.69 (Mar 19) to 26.54, marking an increase of 6.85.
For PBIT Margin (%), as of Mar 20, the value is 23.83. This value exceeds the healthy maximum of 20. It has increased from 16.93 (Mar 19) to 23.83, marking an increase of 6.90.
For PBT Margin (%), as of Mar 20, the value is 24.30. This value is within the healthy range. It has increased from 15.18 (Mar 19) to 24.30, marking an increase of 9.12.
For Net Profit Margin (%), as of Mar 20, the value is 19.83. This value exceeds the healthy maximum of 10. It has increased from 9.70 (Mar 19) to 19.83, marking an increase of 10.13.
For NP After MI And SOA Margin (%), as of Mar 20, the value is 20.27. This value exceeds the healthy maximum of 20. It has increased from 10.17 (Mar 19) to 20.27, marking an increase of 10.10.
For Return on Networth / Equity (%), as of Mar 20, the value is 37.51. This value is within the healthy range. It has increased from 22.71 (Mar 19) to 37.51, marking an increase of 14.80.
For Return on Capital Employeed (%), as of Mar 20, the value is 37.58. This value is within the healthy range. It has increased from 27.83 (Mar 19) to 37.58, marking an increase of 9.75.
For Return On Assets (%), as of Mar 20, the value is 25.69. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.69, marking an increase of 14.40.
For Long Term Debt / Equity (X), as of Mar 20, the value is 0.08. This value is below the healthy minimum of 0.2. It has decreased from 0.20 (Mar 19) to 0.08, marking a decrease of 0.12.
For Total Debt / Equity (X), as of Mar 20, the value is 0.08. This value is within the healthy range. It has decreased from 0.34 (Mar 19) to 0.08, marking a decrease of 0.26.
For Asset Turnover Ratio (%), as of Mar 20, the value is 1.28. It has increased from 1.21 (Mar 19) to 1.28, marking an increase of 0.07.
For Current Ratio (X), as of Mar 20, the value is 1.91. This value is within the healthy range. It has increased from 1.26 (Mar 19) to 1.91, marking an increase of 0.65.
For Quick Ratio (X), as of Mar 20, the value is 1.37. This value is within the healthy range. It has increased from 0.83 (Mar 19) to 1.37, marking an increase of 0.54.
For Inventory Turnover Ratio (X), as of Mar 20, the value is 5.03. This value is within the healthy range. It has decreased from 5.05 (Mar 19) to 5.03, marking a decrease of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 20, the value is 18.23. This value is below the healthy minimum of 20. It has increased from 16.58 (Mar 19) to 18.23, marking an increase of 1.65.
For Dividend Payout Ratio (CP) (%), as of Mar 20, the value is 16.08. This value is below the healthy minimum of 20. It has increased from 13.04 (Mar 19) to 16.08, marking an increase of 3.04.
For Earning Retention Ratio (%), as of Mar 20, the value is 81.77. This value exceeds the healthy maximum of 70. It has decreased from 83.42 (Mar 19) to 81.77, marking a decrease of 1.65.
For Cash Earning Retention Ratio (%), as of Mar 20, the value is 83.92. This value exceeds the healthy maximum of 70. It has decreased from 86.96 (Mar 19) to 83.92, marking a decrease of 3.04.
For Interest Coverage Ratio (X), as of Mar 20, the value is 25.70. This value is within the healthy range. It has increased from 11.29 (Mar 19) to 25.70, marking an increase of 14.41.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 20, the value is 18.74. This value is within the healthy range. It has increased from 6.56 (Mar 19) to 18.74, marking an increase of 12.18.
For Enterprise Value (Cr.), as of Mar 20, the value is 2,474.74. It has increased from 1,821.38 (Mar 19) to 2,474.74, marking an increase of 653.36.
For EV / Net Operating Revenue (X), as of Mar 20, the value is 2.49. This value is within the healthy range. It has increased from 2.15 (Mar 19) to 2.49, marking an increase of 0.34.
For EV / EBITDA (X), as of Mar 20, the value is 9.39. This value is within the healthy range. It has decreased from 10.93 (Mar 19) to 9.39, marking a decrease of 1.54.
For MarketCap / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
For Retention Ratios (%), as of Mar 20, the value is 81.76. This value exceeds the healthy maximum of 70. It has decreased from 83.41 (Mar 19) to 81.76, marking a decrease of 1.65.
For Price / BV (X), as of Mar 20, the value is 4.58. This value exceeds the healthy maximum of 3. It has increased from 4.52 (Mar 19) to 4.58, marking an increase of 0.06.
For Price / Net Operating Revenue (X), as of Mar 20, the value is 2.48. This value is within the healthy range. It has increased from 2.02 (Mar 19) to 2.48, marking an increase of 0.46.
For EarningsYield, as of Mar 20, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 19) to 0.08, marking an increase of 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Alkyl Amines Chemicals Ltd as of June 13, 2025 is: 1,687.03
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, Alkyl Amines Chemicals Ltd is Overvalued by 15.27% compared to the current share price 1,991.00
Intrinsic Value of Alkyl Amines Chemicals Ltd as of June 13, 2025 is: 1,537.33
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, Alkyl Amines Chemicals Ltd is Overvalued by 22.79% compared to the current share price 1,991.00
Last 5 Year EPS CAGR: -8.87%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Alkyl Amines Chemicals Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 37.51% (Industry Average ROE: 10.63%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 54.7 (Industry average Stock P/E: 176.2)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0.08
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Alkyl Amines Chemicals Ltd. is a Public Limited Listed company incorporated on 17/10/1979 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L99999MH1979PLC021796 and registration number is 021796. Currently Company is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company's Total Operating Revenue is Rs. 1571.82 Cr. and Equity Capital is Rs. 10.24 Cr. for the Year ended 31/03/2025.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Alkyl Amines Chemicals Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
